表紙:バイオインピーダンスアナライザーの世界市場 (~2026年): タイプ (単周波・多周波・二周波)・モダリティ (有線・無線)・用途 (部位別測定・全身計測)・エンドユーザー (病院・ホームユーザー)・地域別
市場調査レポート
商品コード
1027226

バイオインピーダンスアナライザーの世界市場 (~2026年): タイプ (単周波・多周波・二周波)・モダリティ (有線・無線)・用途 (部位別測定・全身計測)・エンドユーザー (病院・ホームユーザー)・地域別

Bioimpedance Analyzers Market by Type (Single-frequency, Multiple-frequency, Dual-frequency) Modality (Wired, Wireless) Application (Segmental Body Measurement, Whole Body Measurement) End User (Hospitals, Home Users)-Analysis & Global Forecasts to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 166 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
バイオインピーダンスアナライザーの世界市場 (~2026年): タイプ (単周波・多周波・二周波)・モダリティ (有線・無線)・用途 (部位別測定・全身計測)・エンドユーザー (病院・ホームユーザー)・地域別
出版日: 2021年09月03日
発行: MarketsandMarkets
ページ情報: 英文 166 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

バイオインピーダンスアナライザーの市場規模は予測期間中10.2%のCAGRで推移し、2021年の4億2900万米ドルから、2026年には7億6700万米ドルの規模に成長すると予測されています。

肥満などの生活習慣病の有病率の増加、健康的なライフスタイルに対する意識の高まり、フィットネスクラブや減量クリニック、スポーツリハビリテーションセンターの増加などの要因が同市場の成長を推進しています。

タイプ別で見ると、多周波の部門が予測期間中最大の成長を示すと予測されています。各種疾患の有病率の増加、創薬への関心の高まり、製薬企業によるR%D費の増加などの要因が同部門の成長を牽引しています。また、モダリティ別では、無線部門が同期間中最大の成長を示すと予測されています。ワイヤレス技術の進歩と需要の高まりが同部門の成長を支える主な要因となっています。

当レポートでは、世界のバイオインピーダンスアナライザーの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術・特許の分析、市場規模の推移・予測、製品・モダリティ・用途・ユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 市場機会
    • 課題
  • COVID-19影響分析
  • 範囲・シナリオ
  • バリューチェーン分析
  • サプライチェーン分析
  • ポーターのファイブフォース分析
  • 技術分析
  • 規制状況
  • 特許分析
  • 貿易分析
  • 価格分析
  • エコシステム分析
  • 顧客事業に影響を与える動向

第6章 市場分析・予測:製品別

  • 多周波数生体インピーダンスアナライザー
  • 単一周波数生体インピーダンスアナライザー
  • デュアル周波数生体インピーダンスアナライザー

第7章 市場分析・予測:モダリティ別

  • 無線生体インピーダンスアナライザー
  • 有線生体インピーダンスアナライザー

第8章 市場分析・予測:用途別

  • 部位別測定
  • 全身測定

第9章 市場分析・予測:エンドユーザー別

  • 病院
  • フィットネスクラブ・ウェルネスセンター
  • ホームユーザー
  • その他

第10章 市場分析・予測:地域・主要国別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合情勢

  • 主要企業の成功戦略
  • 市場シェア分析
  • 企業評価マトリックス
  • 企業評価マトリックス(スタートアップ/SME企業)
  • 企業のフットプリント分析

第12章 企業プロファイル

  • 主要企業
    • OMRON CORPORATION
    • TANITA CORPORATION
    • INBODY CO., LTD.
    • RJL SYSTEMS, INC.
    • SECA GMBH & CO. KG
    • EVOLT 360
    • SELVAS HEALTHCARE
    • FOOK TIN GROUP HOLDINGS LTD.
    • BODYSTAT LTD.
    • CHARDER ELECTRONIC CO., LTD.
    • MALTRON INTERNATIONAL
  • スタートアップ/SME企業
    • BIOTEKNA
    • BIODYNAMICS CORPORATION
    • AKERN
    • WITHINGS
    • XIAOMI
    • SINO-HERO(SHENZHEN)BIO-MEDICAL ELECTRONICS CO., LTD.
    • LUMSAIL INDUSTRIAL INC.
    • GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
    • BIOPARHOM
    • MICROLIFE

第13章 付録

目次
Product Code: MD 7973

The global bioimpedance analyzers market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2% from 2021 to 2026. Growth in this market is driven by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.

"Multi-frequency bioimpedance analyzers segment to witness the highest growth during the forecast period."

Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The consumables segment is projected to grow at the highest CAGR during the forecast period. The increasing prevalence of diseases, the growing focus on drug discovery, and the rising R&D expenditure by pharmaceutical companies are the major factor supporting the growth of this segment.

"Wireless bioimpedance modality segment to register the highest growth in the bioimpedance analyzers market during the forecast period."

Based on the modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment is projected to witness the highest growth in the bioimpedance analyzers market during the forecast period. The advancements in and the growing demand for wireless technologies are the major factors supporting the growth of this segment.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

In this report, the bioimpedance analyzers market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising obesity rates in China, growing awareness about health and fitness, and the strong foothold of local players in Japan.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)
  • By Designation: C-level (30%), Director-level (34%), and Others (36%)
  • By Region: North America (40%), Europe (28%), AsiaPacific(20%), and Rest of the World(12%)

List of Companies Profiled in the Report

  • Omron Corporation (Japan)
  • Tanita Corporation (Japan)
  • InBody (South Korea)
  • RJL Systems (US),
  • seca GmbH & Co. KG (Germany)
  • EVOLT 360 (Australia)
  • SELVAS Healthcare (South Korea)
  • Charder Electronic Co. Ltd. (China)
  • Fook Tin Group Holding Ltd. (China)
  • Bodystat Ltd. (UK), Maltron International (UK)
  • Biotekna (Italy), Withings (France)
  • Biodynamics Corporation (US)
  • Akern (Italy)
  • Xiaomi (China)
  • Sino-Hero (Shenzhen)
  • Bio-Medical Electronics Co., Ltd. (China)
  • Lumsail Industrial Inc. (China)
  • Guangzhou Beautylife Electronic Technology Co., Ltd. (China)
  • Bioparhom (France)

Research Coverage

This report studies the bioimpedance analyzers market based on product, modality, application,end user,and region. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total bioimpedance analyzers market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on bioimpedance analyzers products offered by the top 20 players in the bioimpedance analyzers market. The report analyzes the bioimpedance analyzers market by product, modality,application, end user,and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the bioimpedance analyzers market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the bioimpedance analyzers market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 5 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 COVID-19 SPECIFIC ASSUMPTIONS
  • 2.7 RISK ASSESSMENT/FACTOR ANALYSIS
    • TABLE 1 RISK ASSESSMENT/FACTOR ANALYSIS
  • 2.8 COVID-19 HEALTH ASSESSMENT
  • 2.9 COVID-19 ECONOMIC ASSESSMENT
  • 2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO

3 EXECUTIVE SUMMARY

    • FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW
    • FIGURE 14 INCREASING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • 4.2 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION
    • FIGURE 15 SEGMENTAL BODY MEASUREMENT SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
  • 4.3 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY, 2020
    • FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS DOMINATED THE NORTH AMERICAN MARKET IN 2020
  • 4.4 GEOGRAPHICAL SNAPSHOT OF THE BIOIMPEDANCE ANALYZERS MARKET
    • FIGURE 17 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 BIOIMPEDANCE ANALYZERS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of lifestyle diseases
      • 5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles
      • 5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Emerging markets across the Asia Pacific and Latin America
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Inconsistency in the accuracy of different bioimpedance analyzers
  • 5.3 COVID-19 IMPACT ANALYSIS
  • 5.4 RANGES/SCENARIOS
    • 5.4.1 BIOIMPEDANCE ANALYZERS MARKET
    • FIGURE 19 PESSIMISTIC SCENARIO
    • FIGURE 20 OPTIMISTIC SCENARIO
    • FIGURE 21 REALISTIC SCENARIO
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 22 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 23 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 INTENSITY OF COMPETITIVE RIVALRY
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 THREAT OF SUBSTITUTES
  • 5.8 TECHNOLOGY ANALYSIS
  • 5.9 REGULATORY LANDSCAPE
    • FIGURE 24 510(K) APPROVAL PROCESS
  • 5.10 PATENT ANALYSIS
  • 5.11 TRADE ANALYSIS
    • 5.11.1 TRADE ANALYSIS FOR BIOIMPEDANCE ANALYZERS
    • TABLE 2 IMPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 3 EXPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY, 2016-2020 (USD MILLION)
  • 5.12 PRICING ANALYSIS
    • TABLE 4 PRICE RANGE FOR BIOIMPEDANCE ANALYZERS
  • 5.13 ECOSYSTEM ANALYSIS
    • 5.13.1 ROLE IN ECOSYSTEM
    • FIGURE 25 KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS ECOSYSTEM
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS
    • 5.14.2 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS

6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 5 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
  • 6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS
    • 6.2.1 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS SEGMENT DOMINATED THE MARKET IN 2020
    • TABLE 7 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 8 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS
    • 6.3.1 INCREASING OBESE POPULATION TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 9 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 10 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS
    • 6.4.1 INCREASING PREVALENCE OF CHRONIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 11 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 12 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)

7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY

  • 7.1 INTRODUCTION
    • TABLE 13 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 14 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
  • 7.2 WIRELESS BIOIMPEDANCE ANALYZERS
    • 7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
    • TABLE 15 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 16 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 7.3 WIRED BIOIMPEDANCE ANALYZERS
    • 7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE THEIR DEMAND AMONG END USERS
    • TABLE 17 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 18 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)

8 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 20 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
  • 8.2 SEGMENTAL BODY MEASUREMENT
    • 8.2.1 SEGMENTAL BODY MEASUREMENT SEGMENT TO DOMINATE THE BIOIMPEDANCE ANALYZERS MARKET DURING THE FORECAST PERIOD
    • TABLE 21 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 22 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2020-2026 (USD MILLION)
  • 8.3 WHOLE-BODY MEASUREMENT
    • 8.3.1 INCREASING INCIDENCE OF METABOLIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 23 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 24 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT, BY REGION, 2020-2026 (USD MILLION)

9 BIOIMPEDANCE ANALYZERS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 26 BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 9.2 HOSPITALS
    • 9.2.1 INCREASING AWARENESS OF HEALTH AND FITNESS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
    • TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 28 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION, 2020-2026 (USD MILLION)
  • 9.3 FITNESS CLUBS AND WELLNESS CENTERS
    • 9.3.1 FITNESS CLUBS AND WELLNESS CENTERS SEGMENT TO DOMINATE THE BIOIMPEDANCE ANALYZERS MARKET
    • FIGURE 26 US: NUMBER OF HEALTH CLUBS, 2012-2019
    • TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2020-2026 (USD MILLION)
  • 9.4 HOME USERS
    • 9.4.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
    • TABLE 31 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 32 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION, 2020-2026 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 33 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 34 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2020-2026 (USD MILLION)

10 BIOIMPEDANCE ANALYZERS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 35 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017-2019 (USD MILLION)
    • TABLE 36 BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
    • TABLE 37 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 38 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 39 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 40 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 41 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 42 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 43 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 44 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 46 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Increasing number of health clubs and fitness centers driving market growth in the US
    • TABLE 47 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 48 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 49 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 50 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 51 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 52 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 53 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 54 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 High prevalence of obesity in Canada to support market growth
    • TABLE 55 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 56 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 57 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 58 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 59 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 60 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 61 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 62 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 63 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 64 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 65 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 66 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 67 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 68 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 69 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 70 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 71 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 72 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Germany is the largest market for bioimpedance analyzers in Europe
    • TABLE 73 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 74 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 75 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 76 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 77 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 78 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 79 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 80 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 UK is the second-largest market for bioimpedance analyzers in Europe
    • TABLE 81 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 82 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 83 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 84 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 85 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 86 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 87 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 88 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Increasing obese population and rising prevalence of metabolic disorders to drive market growth in France
    • TABLE 89 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 90 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 91 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 92 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 93 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 94 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 95 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 96 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.3.4 REST OF EUROPE
    • TABLE 97 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 98 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 99 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 100 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 101 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 102 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 103 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 104 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT
    • TABLE 105 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017-2019 (USD MILLION)
    • TABLE 106 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020-2026 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 109 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 110 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 111 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 112 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 113 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Strong presence of local players to drive market growth in Japan
    • TABLE 115 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 116 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 117 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 118 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 119 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 120 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 121 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 122 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing obese population to drive market growth in China
    • TABLE 123 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 124 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 125 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 126 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 127 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 128 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 129 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 130 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.3 TAIWAN
      • 10.4.3.1 Increasing incidence of lifestyle diseases to drive market growth in Taiwan
    • TABLE 131 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 132 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 133 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 134 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 135 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 136 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 137 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 138 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Increasing obese population to drive market growth in Australia
    • TABLE 139 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 140 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 141 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 142 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 143 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 144 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 145 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 146 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 147 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 148 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 149 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 150 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 151 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 152 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 153 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 154 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 155 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017-2019 (USD MILLION)
    • TABLE 156 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020-2026 (USD MILLION)
    • TABLE 157 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017-2019 (USD MILLION)
    • TABLE 158 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020-2026 (USD MILLION)
    • TABLE 159 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017-2019 (USD MILLION)
    • TABLE 160 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020-2026 (USD MILLION)
    • TABLE 161 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017-2019 (USD MILLION)
    • TABLE 162 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS MARKET
  • 11.3 MARKET SHARE ANALYSIS
    • TABLE 164 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION
  • 11.4 COMPANY EVALUATION MATRIX
    • 11.4.1 STARS
    • 11.4.2 EMERGING LEADERS
    • 11.4.3 PERVASIVE PLAYERS
    • 11.4.4 PARTICIPANTS
    • FIGURE 29 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET
  • 11.5 COMPANY EVALUATION MATRIX (SMES/START-UPS)
    • 11.5.1 PROGRESSIVE COMPANIES
    • 11.5.2 STARTING BLOCKS
    • 11.5.3 RESPONSIVE COMPANIES
    • 11.5.4 DYNAMIC COMPANIES
    • FIGURE 30 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET (SMES & START-UPS)
  • 11.6 COMPANY FOOTPRINT ANALYSIS
    • TABLE 165 OVERALL FOOTPRINT OF COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET
    • TABLE 166 PRODUCT FOOTPRINT OF COMPANIES
    • TABLE 167 REGIONAL FOOTPRINT OF COMPANIES

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)**
    • 12.1.1 OMRON CORPORATION
    • TABLE 168 OMRON CORPORATION: BUSINESS OVERVIEW
    • FIGURE 31 OMRON CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.2 TANITA CORPORATION
    • TABLE 169 TANITA CORPORATION: BUSINESS OVERVIEW
    • 12.1.3 INBODY CO., LTD.
    • TABLE 170 INBODY CO., LTD.: BUSINESS OVERVIEW
    • 12.1.4 RJL SYSTEMS, INC.
    • TABLE 171 RJL SYSTEMS, INC.: BUSINESS OVERVIEW
    • 12.1.5 SECA GMBH & CO. KG
    • TABLE 172 SECA GMBH & CO. KG: BUSINESS OVERVIEW
    • 12.1.6 EVOLT 360
    • TABLE 173 EVOLT 360: BUSINESS OVERVIEW
    • 12.1.7 SELVAS HEALTHCARE (FORMERLY KNOWN AS JAWON MEDICAL)
    • TABLE 174 SELVAS HEALTHCARE: BUSINESS OVERVIEW
    • 12.1.8 FOOK TIN GROUP HOLDINGS LTD.
    • TABLE 175 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW
    • 12.1.9 BODYSTAT LTD.
    • TABLE 176 BODYSTAT LTD.: BUSINESS OVERVIEW
    • 12.1.10 CHARDER ELECTRONIC CO., LTD.
    • TABLE 177 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW
    • 12.1.11 MALTRON INTERNATIONAL
    • TABLE 178 MALTRON INTERNATIONAL: BUSINESS OVERVIEW
  • *Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
  • 12.2 START-UPS/SME PLAYERS
    • 12.2.1 BIOTEKNA
    • TABLE 179 BIOTEKNA: COMPANY OVERVIEW
    • 12.2.2 BIODYNAMICS CORPORATION
    • TABLE 180 BIODYNAMICS CORPORATION: COMPANY OVERVIEW
    • 12.2.3 AKERN
    • TABLE 181 AKERN: COMPANY OVERVIEW
    • 12.2.4 WITHINGS
    • TABLE 182 WITHINGS: COMPANY OVERVIEW
    • 12.2.5 XIAOMI
    • TABLE 183 XIAOMI: COMPANY OVERVIEW
    • 12.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.
    • TABLE 184 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
    • 12.2.7 LUMSAIL INDUSTRIAL INC.
    • TABLE 185 LUMSAIL INDUSTRIAL INC.: COMPANY OVERVIEW
    • 12.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.
    • TABLE 186 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
    • 12.2.9 BIOPARHOM
    • TABLE 187 BIOPARHOM: COMPANY OVERVIEW
    • 12.2.10 MICROLIFE
    • TABLE 188 MICROLIFE: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS